ReviewFrontiers in immunology2026
Acupuncture in remodeling the tumor microenvironment: current status and challenges.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The tumor microenvironment (TME) is a dynamic ecosystem in which malignant, immune, stromal, and vascular compartments continuously interact, and plays a key role in tumor initiation, development and treatment resistance. In recent years, acupuncture, as an ancient neuromodulatory intervention means of traditional medicine, has shown promise in supportive oncology by attenuating chemotherapy- and radiotherapy-induced toxicities, modulating immunity, and improving quality-of-life metrics. Yet, a mechanistic framework that links acupuncture to TME reprogramming remains to be established. From the perspective of TME, we reviews the latest research status of acupuncture anti-tumor mechanism. Evidence synthesized indicates that acupuncture (i) triggers apoptosis of malignant cells, (ii) re-educates innate (NK, macrophage, dendritic, and mast) and adaptive (T and B lymphocyte) immune subsets, and (iii) normalizes tumor vasculature, so as to inhibit tumor growth and metastasis, synergize chemotherapy and immunotherapy, and promote physical rehabilitation. We further outline opportunities and challenges for translating acupuncture into evidence-based oncology. Using breast cancer as a paradigm, we emphasize the need to evaluate the role of acupuncture in different molecular subtypes and within integrative survivorship care. Furthermore, we aim to link its benefit of relieving symptoms with TME modulation mechanisms, thereby constructing an integrated evidence chain connecting "clinical symptoms-acupuncture intervention-TME modulation-long-term prognosis.". Interdisciplinary trials that couple mechanistic TME readouts with robust clinical endpoints are now warranted to definitively establish the efficacy and safety of acupuncture in cancer care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.